Flux of Dialysis Membrane: Benefit and Risk
Publisher
Springer Singapore
Reference9 articles.
1. Fournier A, Birmelé B, François M, Prat L, Halimi J-M. Factors associated with albumin loss in post-dilution hemodiafiltration and nutritional consequences. Int J Artif Organs. 2015;38(2):75–82.
2. Gejyo F, Homma N, Suzuki Y, Arakawa M. Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med. 1986;314(9):585–6.
3. Kawanishi H, Akiba T, Masakane I, Tomo T, Mineshima M, Kawasaki T, Hirakata H, Akizawa T. Standard on Microbiological Management of Fluids for Hemodialysis and Related Therapies by the Japanese Society for Dialysis Therapy 2008. Ther Apher Dial. 2009;13(2):161–6.
4. Locatelli F, Martin-Malo A, Hannedouche T, Loureiro A, Papadimitriou M, Wizemann V, Jacobson SH, Czekalski S. Claudio Ronco, and Raymond Vanholder, for the membrane permeability outcome (MPO) study group effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol. 2009;20:645–54.
5. Masakane I. Regular dialysis treatment in Japan as of Dec. 31.2014, Japanese society for Dialysis therapy(in Japanese). Toseki Igakkai Zasshi. 2016;49(1):1–34.